| Line 54: |
Line 54: |
| | No treatment is recommended prior to the onset of heart failure. Treatment is aimed at managing congestive heart failure through a combination of drugs. | | No treatment is recommended prior to the onset of heart failure. Treatment is aimed at managing congestive heart failure through a combination of drugs. |
| | The aims of treatment are to: | | The aims of treatment are to: |
| − | #1 '''Reduce Preload''' | + | # '''Reduce Preload''' |
| | *Diuretics to reduce circulating fluid volume (Frusemide, Benzofluazide, Spironolactone, Amiloride) | | *Diuretics to reduce circulating fluid volume (Frusemide, Benzofluazide, Spironolactone, Amiloride) |
| | *Vasodilators to reduce venous return (Nitrates, ACE inhibitors, Alpha antagonists) | | *Vasodilators to reduce venous return (Nitrates, ACE inhibitors, Alpha antagonists) |
| − | #2 '''Reduce Afterload | + | # '''Reduce Afterload |
| | *Vasodilators to decrease systemic vascular resistance | | *Vasodilators to decrease systemic vascular resistance |
| | **ACE inhibitors e.g. Enalapril, Benzapril, Imidopril , | | **ACE inhibitors e.g. Enalapril, Benzapril, Imidopril , |
| Line 63: |
Line 63: |
| | **Calcium channel blockers e.g. Amlodipine | | **Calcium channel blockers e.g. Amlodipine |
| | **Nitrates e.g. Nitropusside | | **Nitrates e.g. Nitropusside |
| − | #3 '''Enhance Systolic function | + | # '''Enhance Systolic function |
| | *Positive Inotropes to increase cardiac contractility and increase cardiac output. | | *Positive Inotropes to increase cardiac contractility and increase cardiac output. |
| | **Pimobendan | | **Pimobendan |
| Line 69: |
Line 69: |
| | **Dobutamine | | **Dobutamine |
| | **Xanthines | | **Xanthines |
| − | #4 '''Improve Diastolic function | + | # '''Improve Diastolic function |
| | *Negative Chronotropes to increase the length of diastole (digoxin, atenolol) | | *Negative Chronotropes to increase the length of diastole (digoxin, atenolol) |
| | *Calcium channel blockers to improve relaxation (amlodipine) | | *Calcium channel blockers to improve relaxation (amlodipine) |
| − | #5 '''Control cardiac arrhythmias using anti-arhythmic drugs | + | # '''Control cardiac arrhythmias using anti-arhythmic drugs |
| | | | |
| | ==Prognosis== | | ==Prognosis== |